Who invested in Topigen Pharmaceuticals?
Topigen Pharmaceuticals's investors include BDC Capital, Desjardins Venture Capital, Fonds de solidarite Ftq, T2C2 Capital and Innovatech Grand Montreal, and 1 more on record.
Canada · Series B startup
Funding summaryUpdated 26 Oct 2026
$24Mraised across 2 rounds since 2004, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Topigen Pharmaceuticals's investors include BDC Capital, Desjardins Venture Capital, Fonds de solidarite Ftq, T2C2 Capital and Innovatech Grand Montreal, and 1 more on record.
Topigen Pharmaceuticals has raised $24M across 2 rounds since 2004.
Topigen Pharmaceuticals's most recent round was a Series B of $5.1M in Oct 2005.
Topigen Pharmaceuticals's largest round on record is $19M (Venture), in Dec 2004.
Topigen Pharmaceuticals's first round on record, in Dec 2004, was backed by BDC Capital, Desjardins Venture Capital and Fonds de solidarite Ftq and 2 others.
Topigen Pharmaceuticals's latest named round is a Series B, in Oct 2005.
Topigen Pharmaceuticals is based in Canada.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.